消风散联合耳穴针刺治疗特应性皮炎:随机对照试验
本研究为随机假针刺对照试验,纳入156例非重度风湿热型特应性皮炎成人患者,均服用消风散汤剂,并随机加用耳穴针刺或假耳穴针刺4周。结果显示,联合耳穴针刺组第4周SCORAD指数较基线下降幅度显著大于假针刺组(MD -9.1;p < 0.0001),DLQI改善也更明显(MD -1.8;p = 0.0362),不良反应轻微短暂。
要点
- 消风散联合耳穴针刺可显著降低非重度风湿热型AD患者SCORAD指数。
- 联合治疗组DLQI改善优于假针刺组,生活质量获益明确。
- 不良反应轻微短暂,支持耳穴针刺作为AD辅助疗法。
核心结论
- 在服用消风散的非重度风湿热型AD成人患者中,加用耳穴针刺较假针刺进一步改善SCORAD和DLQI,安全耐受良好。
研究设计与样本
- 随机、假针刺对照临床试验,纳入156例非重度风湿热型AD成人患者,均服用消风散汤剂,随机分为耳穴针刺组(n=78)和假耳穴针刺组(n=78),干预4周。
主要发现
- 第4周SCORAD指数较基线下降幅度,耳穴针刺组显著大于假针刺组(MD -9.1;p < 0.0001),超过最小临床重要差异。
- DLQI在耳穴针刺组改善更明显(MD -1.8;p = 0.0362)。
- 非索非那定使用量在耳穴针刺组较低,但差异无统计学意义;血清总IgE两组无显著差异。
- 不良事件轻微且短暂。
临床怎么用
- 对非重度风湿热型AD成人患者,可在消风散汤剂基础上加用耳穴针刺以改善皮损严重度和生活质量。
局限性
- 研究仅纳入非重度风湿热型成人患者,结果外推需谨慎。
- 缺乏干预后随访,长期疗效未知。
- 需在更广泛人群和不同传统医学方案中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a considerable burden. Xiao-Feng-San (XFS) has been widely used in traditional medicine for the wind-dampness-heat pattern. Auricular acupuncture (AA) may relieve AD symptoms, but its added benefit with XFS is unclear. METHODS: In this randomized, sham-controlled clinical trial, 156 adults with non-severe AD and wind-dampness-heat pattern, all of whom were prescribed XFS decoction, were additionally assigned to receive either AA (XFS plus AA group, n=78) or sham AA (XFS plus Sham AA group, n=78) for four weeks. The primary outcome was the change in the SCORAD index from baseline to week 4. Secondary outcomes included fexofenadine use, Dermatology Life Quality Index (DLQI), serum total IgE, and adverse events. RESULTS: Compared with the XFS plus sham AA, the XFS plus AA group showed a significantly greater reduction in SCORAD at week 4 (mean difference [MD] -9.1; p < 0.0001), exceeding the minimal clinically important difference. DLQI also improved more in the XFS plus AA group (MD -1.8; p = 0.0362). Fexofenadine use was lower in this group, though not significantly; no significant differences in serum total IgE were found. Adverse events were mild and transient. CONCLUSIONS: Adding AA to XFS enhanced clinical outcomes and quality of life in patients with non-severe AD, with a favorable safety profile. These findings support AA as a promising adjunctive therapy in integrative approaches for AD. Further studies should validate these results across broader populations, with post-intervention follow-up, and diverse traditional medicine regimens. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov (NCT06492902).
引用
- Tran NT, Tran AH, Trinh DT, et al. Efficacy of herbal medicine Xiao-Feng-San combined with auricular acupuncture for atopic dermatitis: A randomized controlled trial. Integr Med Res. 2025. PMID: 41104111. doi:10.1016/j.imr.2025.101256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。